Fundraiser to benefit multiple myeloma research.
When Sidney Moss was diagnosed with multiple myeloma in 2009, the medical outlook was not very good. Treatments were limited at that time for this incurable blood cancer that affects plasma cells. But he underwent a stem cell transplant, followed by drug treatment, that has kept him in remission and healthy. He credits his physician, Jeffrey Margolis, M.D., with helping him by recommending a specific treatment.
“I’ve been very lucky,” says Moss, 76, a Bloomfield Township resident whose business is self-storage facilities and manufactured home communities. “I’m the kind of person who wants to be involved. There were limited drugs and resources for patients,” he says, adding he wanted to help others.
So, Moss decided to organize a fundraiser for multiple myeloma research featuring things that he enjoys — “good food, good wine and jazz.” The eighth Wine and Dine in D will be held on Thursday, Oct. 4, at the Westin Book Cadillac in Detroit with 400 guests expected. All the food and beverages are donated. A physician panel will begin the event with a discussion about new treatments for multiple myeloma.
Approximately 25,000 Americans are diagnosed with multiple myeloma annually. This blood cancer affects plasma cells that accumulate in bone marrow, crowding out the normal cells that fight infection and creating an abnormal antibody that can cause life-threatening problems. While not curable, it is considered “highly manageable” today with treatments including immunotherapy, radiation, stem cell transplant, targeted biologic agents and chemotherapy.
The previous seven fundraisers have raised about $1 million, according to Moss. Ninety percent of the funds raised are donated to the Multiple Myeloma Research Foundation, which has advanced the genomic sequencing of multiple myeloma, funded research grants and brought new drugs to market.
“Less than 20 years ago, people who got the disease were only expected to live a couple of years. That has all changed,” Moss says. “There are numerous drugs currently on the market that came from Multiple Myeloma Research Foundation support for clinical trials and research, and they continually support testing for more.”
Most of the remaining funds are used to help local patients, including educational breakfasts that allow them to meet cancer specialists and ask specific questions about the disease and its treatment. Moss created a nonprofit organization, Cure Multiple Myeloma Corporation, to operate in conjunction with the benefit in 2015.
Paula Korelitz, a Wine and Dine in the D volunteer for several years, describes Moss as “a Jewish man who has done something for the community, not just himself.”
Wine & Dine in the D will begin at 5:30 p.m. Thursday, Oct. 4, at the Westin Book Cadillac in Detroit with a physician panel discussion. A strolling dinner begins at 6 p.m., with jazz by Ursula Walker and the Buddy Budson Quintet, and a silent auction. Tickets are $175-$275, with reduced rates for multiple myeloma patients. Call Sharon Kelly at (248) 449-6663 or visit bit.ly/2DCtQb9.